Safety of rush immunotherapy using a modified schedule: A cumulative experience of 893 patients receiving multiple aeroallergens

Allergy and Asthma Proceedings

Volumn 28, Issue 3, 2007, Pages 305-312

  Smits, William L ^a,b   Giese, Jeannie K ^a   Letz, Kevin L ^a,c   Inglefield, Joseph T ^d   Schlie, Austin R ^a  

^a Allergy and Asthma Center   (United States)

^b PURDUE UNIVERSITY FORT WAYNE   (United States)

^c INDIANA WESLEYAN UNIVERSITY   (United States)

^d Hickory Allergy and Asthma Center   (United States)

Author keywords

Allergen immunotherapy; Allergen vaccination; Allergic asthma; Allergy; Asthma; Efficacy; Rapid desensitization; Rush immunotherapy

Indexed keywords

ALLERGEN; HISTAMINE H1 RECEPTOR ANTAGONIST; PREDNISONE; VACCINE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; ASTHMA; CHILD; DESENSITIZATION; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; MIDDLE AGED; PERENNIAL RHINITIS; PRESCHOOL CHILD; SAFETY; SINUSITIS; SKIN TEST;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANAPHYLAXIS; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; MALE; MIDDLE AGED; PREDNISONE; RHINITIS, ALLERGIC, PERENNIAL; SAFETY; SINUSITIS; SKIN TESTS; VACCINES, COMBINED;

EID: 34447269454     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2996     Document Type: Article

References (32)

1. Creticos PS. Immunotherapy with allergens. JAMA 268:2834-2839, 1992.
2. McHugh SM, Lavelle B, Kemeny DM, et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronysinus in allergic rhinitis, comparing clinical outcome with changes in antigen specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 86:521-531, 1990.
3. Norman P, and Van Metre TE. The safety of allergenic immunotherapy. J Allergy Clin Immunol 85:522-525, 1990.
4. Ross R, Nelson H, and Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: An analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther 22:342-350, 2000.
5. Bousquet J, and Michel FB. Specific immunotherapy in asthma: Is it effective? J Allergy Clin Immunol 94:1-11, 1994.
6. Cantani A, Businco E, Benincori N, et al. A three-year controlled study in children with pollinosis treated with immunotherapy. Ann Allergy 53:79-84, 1984.
7. Cantani A, Arcese G, Lucenti P, et al. A three-year prospective study of specific immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma. J Investig Allergol Clin Immunol 7:90-97, 1997.
8. Haugaard L, Dahl R, and Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purifed extract of house dust mite: Clinical efficacy and side effects. J Allergy Clin Immunol 91:709-722, 1993.
9. Malling HJ. Allergen-specific immune therapy in the treatment of asthma. Ugeskr Laeger 162:477-479, 2000.
10. Nagata M, Yamamoto H, Tabe K, et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: Changes in in vivo and in vitro responses to HDM. Intern Med 32:702-709, 1993.
11. Ross R, Nelson H, and Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: A meta analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 22:329-341, 2000.
12. Bernstein DI, Mittman RJ, Kagen SL, et al. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 84:951-959, 1989.
13. Ross R, Nelson H, and Finegold I. Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysis. Clin Ther 22:351-358, 2000.
14. Secrist H, Chelen CJ, Wen Y, et al. Allergy immunotherapy decreases interleukin-4 production in CD4 and T-cells from allergic individuals. J Exp Med 178:2123-2130, 1993.
15. Cohn JR, and Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 91:734-737, 1993.
16. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 70:480-482, 1993.
17. Bousquet J, Calvayrac P, Guerin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 76:734-744, 1985.
18. Hejjaoui A, Ferrando R, Dhivert H, et al. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 89:925-933, 1992.
19. Bousquet J, Guerin B, Dotte A, et al. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Clin Allergy 15:179-192, 1985.
20. Sundin B, Lilja G, Graff-Lonnevig V, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 77:478-487, 1986.
21. Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol with patients suffering from asthma. J Allergy Clin Immunol 83:797-802, 1989.
22. Hejjaoui A, Dhivert H, Michel FB, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 85:473-479, 1990.
23. Portnoy J, King K, Kanarek H, et al. Incidence of systemic reactions during rush immunotherapy. Ann Allergy 68:493-498, 1992.
24. Stewart GE II, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 90:567-578, 1992.
25. Harvey S, Laurie S, Hilton K, et al. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol 92:414-419, 2004.
26. Sharkey P, and Portnoy J. Rush immunotherapy: Experience with a one-day schedule. Ann Allergy Asthma Immunol 76:175-180, 1996.
27. Smits W, Inglefield JT, Letz K, et al. Improved immunotherapy with a rapid allergen vaccination schedule: A study of 137 patients. Ear Nose Throat J 82:881-887, 2003.
28. Nielson L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled study. J Allergy Clin Immunol 97:1207-1213, 1996.
29. Portnoy J, Bagstad K, Kanarek H, et al. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy 73:409-418, 1994.
30. Smits W, Giese J, Letz K, et al. Safety of rapid allergen vaccination in children utilizing a 2.5-hour protocol. Ped Asthma Allergy Immunol 18:131-139, 2005.
31. Bousquet J, Lockey R, and Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. Eur J Allergy Clin Immunol 53:1-42, 1998.
32. Rudd S. Immunotherapy compliance - A shot in the dark. Ann Allergy Asthma Immunol 74:195-198, 1995.